Free Trial
OTCMKTS:ABCZF

Abcam (ABCZF) Stock Price, News & Analysis

Abcam logo
C$22.25 0.00 (0.00%)
As of 03/31/2025

About Abcam Stock (OTCMKTS:ABCZF)

Key Stats

Today's Range
C$22.25
C$22.25
50-Day Range
C$22.25
C$22.25
52-Week Range
C$5.00
C$23.80
Volume
N/A
Average Volume
2,659 shs
Market Capitalization
N/A
P/E Ratio
130.73
Dividend Yield
0.32%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Abcam Limited, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. Abcam Limited was formerly known as Abcam plc and changed its name to Abcam Limited in December 2023. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. As of December 6, 2023, Abcam Limited operates as a subsidiary of Danaher Corporation.

Remove Ads
Receive ABCZF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter.

ABCZF Stock News Headlines

Abcam (OTC:ABCZF), Short Interest Report
Revealed: The Chip Stock Redefining AI as We Know It
In this urgent presentation, Wall Street's so-called "AI Oracle" unveils the name of a small American tech firm poised to disrupt the $1 trillion semiconductor industry. He's the same expert who spotted Apple before the iPhone, Amazon before it dominated retail, and Google before it became a verb. Back then, Wall Street shrugged. They're doing it again—ignoring his latest prediction. But according to his research, what we've seen from AI so far is just the beginning. The real boom is still ahead.
Which way now for the Abcam share price?
See More Headlines

ABCZF Stock Analysis - Frequently Asked Questions

Abcam's stock was trading at C$22.25 at the start of the year. Since then, ABCZF shares have increased by 0.0% and is now trading at C$22.25.
View the best growth stocks for 2025 here
.

Shares of ABCZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:ABCZF
Fax
N/A
Employees
1,750
Year Founded
N/A

Profitability

Trailing P/E Ratio
130.73
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (OTCMKTS:ABCZF) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners